Pharmacogenomics of Lithium Response in Bipolar Disorder

Despite being the most widely studied mood stabilizer, researchers have not confirmed a mechanism for lithium’s therapeutic efficacy in Bipolar Disorder (BD). Pharmacogenomic applications may be clinically useful in the future for identifying lithium-responsive patients and facilitating personalized...

Descripción completa

Detalles Bibliográficos
Autores principales: Vecera, Courtney M., Fries, Gabriel R., Shahani, Lokesh R., Soares, Jair C., Machado-Vieira, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063790/
https://www.ncbi.nlm.nih.gov/pubmed/33804842
http://dx.doi.org/10.3390/ph14040287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063790/
https://www.ncbi.nlm.nih.gov/pubmed/33804842
http://dx.doi.org/10.3390/ph14040287

Ejemplares similares